Boris Fehse

发表

Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation

M. Heuser, F. Thol, A. Ganser, 2014, Leukemia.

Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors

H. Katus, J. Kleinschmidt, B. Fehse, 2015, Gene Therapy.

TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer

D. Atanackovic, B. Fehse, B Berdien, 2014, Gene Therapy.

Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM

N. Kröger, A. Zander, B. Fehse, 2008, Bone Marrow Transplantation.

Lentiviral gene ontology (LeGO) vectors equipped with novel drug-selectable fluorescent proteins: new building blocks for cell marking and multi-gene analysis

B. Fehse, U. Bartsch, U. Mock, 2010, Gene Therapy.

Amphotropic and VSV-G-pseudotyped retroviral vectors transduce human hematopoietic progenitor cells with similar efficiency

B. Fehse, C. Baum, D. Laer, 2000, Bone Marrow Transplantation.

Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene.

A. Zander, B. Fehse, W. Ostertag, 1997, Human gene therapy.

JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

Y. Hildebrandt, N. Kröger, A. Zander, 2009, Blood.

Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways.

F. Staal, M. Goodell, S. M. Chambers, 2007, Blood.

Insertional mutagenesis and clonal dominance: biological and statistical considerations

B. Fehse, I. Roeder, Boris Fehse, 2008, Gene Therapy.

Self-inactivating retroviral vectors with improved RNA processing

A. Schambach, B. Fehse, U. Modlich, 2004, Gene Therapy.

Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT

N. Kröger, A. Zander, B. Fehse, 2010, Bone Marrow Transplantation.

Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking

B. Fehse, W. Ostertag, M. Hildinger, 1999, Gene Therapy.

Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.

N. Kröger, A. Zander, B. Fehse, 2001, Journal of hematotherapy & stem cell research.

Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR.

C. Wolschke, R. Massoud, P. Freiberger, 2024, Leukemia.